ClinicalTrials.gg
Sign In
RecruitingNCT07879872Updated Oct 19, 2026

Conducting Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up for Post-discharge Ostomy Patients to Reduce Hospital Readmission

An interventional study of Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up in Ostomy, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Supportive care

Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is to assess the impact of a telephone follow-up visit on rehospitalizations after ostomy surgery.

02

Conditions studied

  • Ostomy
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,263 studies on the registry; 670 are open to participants now.

Of its 450 completed or terminated interventional studies of FDA-regulated products, 318 (71%) have results posted.

Browse Mayo Clinic studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All adult patients with new ostomy
  • Able to consent to participate in the study
  • English speaking
  • Patients who are willing to participate

Exclusion criteria

Exclusion Criteria:

  • ostomy revision surgery
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up

    Prospective adult patients discharged with a new ostomy who consent to participate and receive a scripted telephone follow-up call within 1 week after hospital discharge.

    Behavioral: Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up

  • No intervention
    Standard of Care

    Retrospective standard-of-care control group

Interventions

  • BehavioralWound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up

    Participants assigned to the intervention will receive a structured post-discharge telephone follow-up call from a Wound, Ostomy, and Continence nurse within 1 week after hospital discharge.

06

What researchers measure

Primary outcomes

  1. Ostomy-Related Hospital Readmission

    Ostomy related hospital readmission

    Time frame: 30 days after hospital discharge

Secondary outcomes

  1. Emergency Department Visits

    Ostomy related emergency department visits

    Time frame: 30 days after hospital discharge

07

Study locations

1 of 1 sites recruiting
  • Mayo Clinic
    Phoenix, Arizona 85054, United States
    • Mary Josephine Famorca, DNP · Contact · 480-342-1332
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Oct 2028, 23 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 12, 2026
First posted
Oct 19, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Oct 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07879872
Lead sponsor
Mayo Clinic
Responsible party
Mary Josephine Famorca (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Oct 19, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Oct 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Oct 19, 2026

Study contacts

Mary Josephine Famorca, DNP
Contact
Famorca.Mary@mayo.edu
480-342-1332
Samantha Conley, PhD, RN
Contact
Conley.Samantha@mayo.edu
507-255-1038
Mary Josephine Famorca, DNP
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Mayo Clinic →

Start the discussion